Revenue increased 7.7%
Revenue changed +7.7% from the comparable as-filed period.
$358.9M→$386.6M3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +7.7% from the comparable as-filed period.
Gross profit changed +16.8% from the comparable as-filed period.
Selling, general & administrative changed +6.6% from the comparable as-filed period.
Inventory changed -4.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.